Table 1:
Parameter | Cost |
---|---|
Facility HIV test(32) | |
HIV− test | $3.62 |
HIV+ test | $5.62 |
ART costs per year (including supply chain)(18) | |
1st line regimen* | $90 |
2nd line regimen§ | $318 |
ART program costs per year (health facility) | $80 |
ART program costs per year (DSD due to VL <1000) | $40 |
Annual health-care for HIV-positive persons not in care(33) | |
CD4 count >350 cells per μL | $11 |
CD4 count >200–350 cells per μL | $39 |
CD4 count ≤200 cells per μL | $142 |
End of life care (per death) | $136 |
Diagnostic tests (centralized laboratory)(6) | |
CD4 | $6.03 |
VL test | $25.98 |
Creatinine | $3.41 |
Diagnostic tests (POC) by monthly clinic volume(6) ¥ | |
Clinic volume 10 | |
CD4 | $24.41 |
VL | $46.51 |
Creatinine | $9.71 |
Clinic volume 20 | |
CD4 | $16.09 |
VL | $33.31 |
Creatinine | $9.14 |
Clinic volume 30 | |
CD4 | $13.32 |
VL | $28.91 |
Creatinine | $8.96 |
Clinic volume 40 | |
CD4 | $11.94 |
VL | $26.71 |
Creatinine | $8.86 |
Clinic volume 50 | |
CD4 | $11.11 |
VL | $25.39 |
Creatinine | $8.81 |
ART: antiretroviral therapy, DSD: differentiated service delivery, POC: point-of-care, VL: viral load. HIV test and diagnostic test costs refer to cost per test conducted.
1st line ART regimen consisting of tenofovir, lamivudine, and efavirenz
2nd line ART regimen consisting of lopinavir/ritonavir
Clinic volume refers to the number of patient initiating ART per month